nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—hematologic cancer	0.186	1	CpDpCtD
Caffeine—ATM—hematologic cancer	0.0844	0.251	CbGaD
Caffeine—PIK3CD—hematologic cancer	0.0772	0.23	CbGaD
Caffeine—PIK3CB—hematologic cancer	0.0772	0.23	CbGaD
Caffeine—PIK3CA—hematologic cancer	0.0597	0.178	CbGaD
Caffeine—PDE4B—hematologic cancer	0.0305	0.0907	CbGaD
Caffeine—CYP1B1—Procarbazine—hematologic cancer	0.0228	0.0846	CbGbCtD
Caffeine—CYP1B1—Daunorubicin—hematologic cancer	0.0122	0.0453	CbGbCtD
Caffeine—CYP1B1—Dasatinib—hematologic cancer	0.00752	0.0279	CbGbCtD
Caffeine—CYP1B1—Mitoxantrone—hematologic cancer	0.00743	0.0276	CbGbCtD
Caffeine—ABCB1—hematologic cancer	0.00697	0.0207	CbGaD
Caffeine—CYP1A2—Anagrelide—hematologic cancer	0.0059	0.0219	CbGbCtD
Caffeine—CYP1A1—Methoxsalen—hematologic cancer	0.0059	0.0219	CbGbCtD
Caffeine—CYP1A1—Bortezomib—hematologic cancer	0.00561	0.0208	CbGbCtD
Caffeine—CYP1A1—Daunorubicin—hematologic cancer	0.00537	0.0199	CbGbCtD
Caffeine—CYP1A1—Thalidomide—hematologic cancer	0.00489	0.0181	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—hematologic cancer	0.0042	0.0156	CbGbCtD
Caffeine—CYP1B1—Dexamethasone—hematologic cancer	0.00385	0.0143	CbGbCtD
Caffeine—CYP2E1—Thalidomide—hematologic cancer	0.00378	0.014	CbGbCtD
Caffeine—CYP2C9—Bexarotene—hematologic cancer	0.00368	0.0137	CbGbCtD
Caffeine—ABCB1—Lenalidomide—hematologic cancer	0.00358	0.0133	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00344	0.0128	CbGbCtD
Caffeine—CYP3A7—Ifosfamide—hematologic cancer	0.00344	0.0128	CbGbCtD
Caffeine—CYP1A1—Dasatinib—hematologic cancer	0.0033	0.0122	CbGbCtD
Caffeine—CYP3A7—Imatinib—hematologic cancer	0.00329	0.0122	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00329	0.0122	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—hematologic cancer	0.00325	0.012	CbGbCtD
Caffeine—CYP2C8—Bortezomib—hematologic cancer	0.00324	0.012	CbGbCtD
Caffeine—CYP3A5—Daunorubicin—hematologic cancer	0.00322	0.0119	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—hematologic cancer	0.0032	0.0119	CbGbCtD
Caffeine—CYP2D6—Lomustine—hematologic cancer	0.00313	0.0116	CbGbCtD
Caffeine—CYP1A2—Carmustine—hematologic cancer	0.0031	0.0115	CbGbCtD
Caffeine—CYP2C9—Idarubicin—hematologic cancer	0.00305	0.0113	CbGbCtD
Caffeine—CYP3A5—Thalidomide—hematologic cancer	0.00293	0.0109	CbGbCtD
Caffeine—CYP3A5—Teniposide—hematologic cancer	0.0028	0.0104	CbGbCtD
Caffeine—CYP2D6—Idarubicin—hematologic cancer	0.00279	0.0104	CbGbCtD
Caffeine—CYP1A2—Methoxsalen—hematologic cancer	0.00264	0.00977	CbGbCtD
Caffeine—CYP3A5—Ifosfamide—hematologic cancer	0.00258	0.00958	CbGbCtD
Caffeine—CYP2E1—Mitoxantrone—hematologic cancer	0.00252	0.00934	CbGbCtD
Caffeine—CYP1A2—Bortezomib—hematologic cancer	0.00251	0.00929	CbGbCtD
Caffeine—CYP2C8—Ifosfamide—hematologic cancer	0.00248	0.00921	CbGbCtD
Caffeine—CYP3A5—Imatinib—hematologic cancer	0.00247	0.00915	CbGbCtD
Caffeine—CYP1A2—Daunorubicin—hematologic cancer	0.0024	0.00889	CbGbCtD
Caffeine—CYP2D6—Hydroxyurea—hematologic cancer	0.00237	0.0088	CbGbCtD
Caffeine—CYP1A2—Alitretinoin—hematologic cancer	0.00235	0.00871	CbGbCtD
Caffeine—CYP2C9—Bortezomib—hematologic cancer	0.00226	0.00837	CbGbCtD
Caffeine—CYP1A2—Thalidomide—hematologic cancer	0.00218	0.0081	CbGbCtD
Caffeine—CYP2C8—Nilotinib—hematologic cancer	0.00216	0.00799	CbGbCtD
Caffeine—CYP3A4—Bexarotene—hematologic cancer	0.00214	0.00794	CbGbCtD
Caffeine—ABCB1—Daunorubicin—hematologic cancer	0.0021	0.00777	CbGbCtD
Caffeine—CYP2D6—Bortezomib—hematologic cancer	0.00207	0.00766	CbGbCtD
Caffeine—CYP3A7—Irinotecan—hematologic cancer	0.00205	0.00762	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00205	0.00762	CbGbCtD
Caffeine—ABCB1—Alitretinoin—hematologic cancer	0.00205	0.00762	CbGbCtD
Caffeine—CYP3A4—Lomustine—hematologic cancer	0.00199	0.00739	CbGbCtD
Caffeine—CYP3A4—Busulfan—hematologic cancer	0.00199	0.00739	CbGbCtD
Caffeine—CYP3A5—Dasatinib—hematologic cancer	0.00198	0.00735	CbGbCtD
Caffeine—CYP2C9—Thalidomide—hematologic cancer	0.00197	0.0073	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—hematologic cancer	0.00188	0.00696	CbGbCtD
Caffeine—CYP2C9—Teniposide—hematologic cancer	0.00188	0.00696	CbGbCtD
Caffeine—CYP1A2—Imatinib—hematologic cancer	0.00184	0.00681	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0018	0.00666	CbGbCtD
Caffeine—CYP3A7—Vincristine—hematologic cancer	0.0018	0.00666	CbGbCtD
Caffeine—CYP3A4—Thiotepa—hematologic cancer	0.00178	0.00658	CbGbCtD
Caffeine—CYP2C9—Ifosfamide—hematologic cancer	0.00173	0.00642	CbGbCtD
Caffeine—CYP1A1—Dexamethasone—hematologic cancer	0.00169	0.00627	CbGbCtD
Caffeine—CYP2C9—Imatinib—hematologic cancer	0.00165	0.00614	CbGbCtD
Caffeine—ABCB1—Imatinib—hematologic cancer	0.00161	0.00595	CbGbCtD
Caffeine—CYP2E1—Etoposide—hematologic cancer	0.00159	0.00589	CbGbCtD
Caffeine—CYP3A5—Irinotecan—hematologic cancer	0.00154	0.00571	CbGbCtD
Caffeine—CYP2D6—Imatinib—hematologic cancer	0.00151	0.00561	CbGbCtD
Caffeine—CYP2C9—Nilotinib—hematologic cancer	0.0015	0.00558	CbGbCtD
Caffeine—CYP1A2—Dasatinib—hematologic cancer	0.00147	0.00547	CbGbCtD
Caffeine—ABCB1—Nilotinib—hematologic cancer	0.00146	0.00541	CbGbCtD
Caffeine—ABCB1—Vinorelbine—hematologic cancer	0.00145	0.00537	CbGbCtD
Caffeine—CYP3A4—Methoxsalen—hematologic cancer	0.00138	0.00512	CbGbCtD
Caffeine—CYP2D6—Nilotinib—hematologic cancer	0.00137	0.0051	CbGbCtD
Caffeine—CYP2D6—Vinorelbine—hematologic cancer	0.00136	0.00506	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00135	0.00502	CbGbCtD
Caffeine—CYP3A7—Dexamethasone—hematologic cancer	0.00135	0.00502	CbGbCtD
Caffeine—CYP3A5—Vincristine—hematologic cancer	0.00135	0.00499	CbGbCtD
Caffeine—CYP3A4—Bortezomib—hematologic cancer	0.00131	0.00487	CbGbCtD
Caffeine—CYP2E1—Dexamethasone—hematologic cancer	0.00131	0.00484	CbGbCtD
Caffeine—ABCB1—Dasatinib—hematologic cancer	0.00129	0.00478	CbGbCtD
Caffeine—ABCB1—Mitoxantrone—hematologic cancer	0.00127	0.00472	CbGbCtD
Caffeine—CYP3A4—Daunorubicin—hematologic cancer	0.00126	0.00466	CbGbCtD
Caffeine—CYP3A5—Etoposide—hematologic cancer	0.00123	0.00458	CbGbCtD
Caffeine—ATM—hematopoietic system—hematologic cancer	0.0012	0.0369	CbGeAlD
Caffeine—CYP2C8—Etoposide—hematologic cancer	0.00119	0.0044	CbGbCtD
Caffeine—ABCB1—Betamethasone—hematologic cancer	0.00114	0.00421	CbGbCtD
Caffeine—ABCB1—Gemcitabine—hematologic cancer	0.00113	0.00417	CbGbCtD
Caffeine—ABCB1—Prednisolone—hematologic cancer	0.00112	0.00415	CbGbCtD
Caffeine—CYP3A4—Cytarabine—hematologic cancer	0.00111	0.00411	CbGbCtD
Caffeine—CYP3A4—Teniposide—hematologic cancer	0.00109	0.00405	CbGbCtD
Caffeine—PIK3CD—hematopoietic system—hematologic cancer	0.00106	0.0327	CbGeAlD
Caffeine—ABCB1—Prednisone—hematologic cancer	0.00106	0.00392	CbGbCtD
Caffeine—CYP3A5—Dexamethasone—hematologic cancer	0.00101	0.00376	CbGbCtD
Caffeine—CYP3A4—Ifosfamide—hematologic cancer	0.00101	0.00373	CbGbCtD
Caffeine—ABCB1—Irinotecan—hematologic cancer	0.001	0.00372	CbGbCtD
Caffeine—CYP2C8—Dexamethasone—hematologic cancer	0.000976	0.00362	CbGbCtD
Caffeine—CYP3A4—Imatinib—hematologic cancer	0.000962	0.00357	CbGbCtD
Caffeine—PIK3CB—hematopoietic system—hematologic cancer	0.000926	0.0285	CbGeAlD
Caffeine—CYP1A2—Etoposide—hematologic cancer	0.000919	0.00341	CbGbCtD
Caffeine—PIK3CA—hematopoietic system—hematologic cancer	0.000916	0.0282	CbGeAlD
Caffeine—CYP3A4—Ruxolitinib—hematologic cancer	0.000906	0.00336	CbGbCtD
Caffeine—ABCB1—Vinblastine—hematologic cancer	0.000892	0.00331	CbGbCtD
Caffeine—ABCB1—Vincristine—hematologic cancer	0.000877	0.00325	CbGbCtD
Caffeine—CYP3A4—Nilotinib—hematologic cancer	0.000874	0.00324	CbGbCtD
Caffeine—CYP3A4—Vinorelbine—hematologic cancer	0.000867	0.00321	CbGbCtD
Caffeine—CYP2C9—Cisplatin—hematologic cancer	0.000843	0.00312	CbGbCtD
Caffeine—CYP2D6—Vinblastine—hematologic cancer	0.00084	0.00312	CbGbCtD
Caffeine—ABCB1—Cisplatin—hematologic cancer	0.000818	0.00303	CbGbCtD
Caffeine—ABCB1—Etoposide—hematologic cancer	0.000803	0.00298	CbGbCtD
Caffeine—ATM—blood—hematologic cancer	0.000793	0.0244	CbGeAlD
Caffeine—CYP3A4—Triamcinolone—hematologic cancer	0.000793	0.00294	CbGbCtD
Caffeine—CYP3A4—Dasatinib—hematologic cancer	0.000773	0.00287	CbGbCtD
Caffeine—ATM—bone marrow—hematologic cancer	0.000767	0.0236	CbGeAlD
Caffeine—CYP3A4—Mitoxantrone—hematologic cancer	0.000763	0.00283	CbGbCtD
Caffeine—PRKDC—blood—hematologic cancer	0.00075	0.0231	CbGeAlD
Caffeine—PRKDC—bone marrow—hematologic cancer	0.000726	0.0224	CbGeAlD
Caffeine—PIK3CB—gonad—hematologic cancer	0.000704	0.0217	CbGeAlD
Caffeine—PIK3CD—blood—hematologic cancer	0.000703	0.0217	CbGeAlD
Caffeine—PIK3CA—gonad—hematologic cancer	0.000697	0.0215	CbGeAlD
Caffeine—ATM—lung—hematologic cancer	0.000695	0.0214	CbGeAlD
Caffeine—PIK3CD—bone marrow—hematologic cancer	0.000681	0.021	CbGeAlD
Caffeine—CYP2C9—Dexamethasone—hematologic cancer	0.000681	0.00252	CbGbCtD
Caffeine—CYP3A4—Betamethasone—hematologic cancer	0.00068	0.00252	CbGbCtD
Caffeine—CYP3A4—Prednisolone—hematologic cancer	0.000671	0.00249	CbGbCtD
Caffeine—ABCB1—Dexamethasone—hematologic cancer	0.000661	0.00245	CbGbCtD
Caffeine—PRKDC—lung—hematologic cancer	0.000657	0.0203	CbGeAlD
Caffeine—ATM—testis—hematologic cancer	0.000656	0.0202	CbGeAlD
Caffeine—CYP3A4—Prednisone—hematologic cancer	0.000634	0.00235	CbGbCtD
Caffeine—CYP2D6—Dexamethasone—hematologic cancer	0.000622	0.00231	CbGbCtD
Caffeine—PRKDC—testis—hematologic cancer	0.00062	0.0191	CbGeAlD
Caffeine—PIK3CD—lung—hematologic cancer	0.000617	0.019	CbGeAlD
Caffeine—PIK3CB—blood—hematologic cancer	0.000614	0.0189	CbGeAlD
Caffeine—PIK3CA—blood—hematologic cancer	0.000607	0.0187	CbGeAlD
Caffeine—RYR1—blood—hematologic cancer	0.000607	0.0187	CbGeAlD
Caffeine—CYP3A4—Irinotecan—hematologic cancer	0.000601	0.00223	CbGbCtD
Caffeine—PIK3CB—bone marrow—hematologic cancer	0.000594	0.0183	CbGeAlD
Caffeine—PIK3CA—bone marrow—hematologic cancer	0.000588	0.0181	CbGeAlD
Caffeine—PIK3CD—testis—hematologic cancer	0.000582	0.0179	CbGeAlD
Caffeine—ADORA2A—hematopoietic system—hematologic cancer	0.000561	0.0173	CbGeAlD
Caffeine—ABCB1—Doxorubicin—hematologic cancer	0.000548	0.00203	CbGbCtD
Caffeine—PIK3CB—lung—hematologic cancer	0.000538	0.0166	CbGeAlD
Caffeine—CYP3A4—Vinblastine—hematologic cancer	0.000534	0.00198	CbGbCtD
Caffeine—PIK3CA—lung—hematologic cancer	0.000532	0.0164	CbGeAlD
Caffeine—ABCB1—Methotrexate—hematologic cancer	0.000531	0.00197	CbGbCtD
Caffeine—CYP3A4—Vincristine—hematologic cancer	0.000525	0.00195	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—hematologic cancer	0.000516	0.00191	CbGbCtD
Caffeine—Oxtriphylline—HDAC2—hematologic cancer	0.000508	0.254	CrCbGaD
Caffeine—PIK3CB—testis—hematologic cancer	0.000507	0.0156	CbGeAlD
Caffeine—RYR1—testis—hematologic cancer	0.000502	0.0155	CbGeAlD
Caffeine—PIK3CA—testis—hematologic cancer	0.000502	0.0155	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vinorelbine—hematologic cancer	0.000495	0.445	CbGdCrCtD
Caffeine—ADORA1—hematopoietic system—hematologic cancer	0.000484	0.0149	CbGeAlD
Caffeine—CYP3A4—Etoposide—hematologic cancer	0.000481	0.00178	CbGbCtD
Caffeine—ATM—lymph node—hematologic cancer	0.000476	0.0146	CbGeAlD
Caffeine—PRKDC—lymph node—hematologic cancer	0.00045	0.0139	CbGeAlD
Caffeine—ADORA2B—blood—hematologic cancer	0.000447	0.0138	CbGeAlD
Caffeine—ADORA2A—gonad—hematologic cancer	0.000427	0.0131	CbGeAlD
Caffeine—PIK3CD—lymph node—hematologic cancer	0.000422	0.013	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vincristine—hematologic cancer	0.000396	0.356	CbGdCrCtD
Caffeine—CYP3A4—Dexamethasone—hematologic cancer	0.000396	0.00147	CbGbCtD
Caffeine—ADORA2B—lung—hematologic cancer	0.000392	0.0121	CbGeAlD
Caffeine—ADORA2A—blood—hematologic cancer	0.000372	0.0114	CbGeAlD
Caffeine—ADORA2B—testis—hematologic cancer	0.00037	0.0114	CbGeAlD
Caffeine—PIK3CB—lymph node—hematologic cancer	0.000368	0.0113	CbGeAlD
Caffeine—PIK3CA—lymph node—hematologic cancer	0.000364	0.0112	CbGeAlD
Caffeine—PDE4B—hematopoietic system—hematologic cancer	0.000358	0.011	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—hematologic cancer	0.000328	0.00122	CbGbCtD
Caffeine—Theophylline—HDAC2—hematologic cancer	0.000308	0.154	CrCbGaD
Caffeine—ADORA2A—testis—hematologic cancer	0.000307	0.00947	CbGeAlD
Caffeine—CYP1B1—hematopoietic system—hematologic cancer	0.000307	0.00946	CbGeAlD
Caffeine—Theobromine—PDE4B—hematologic cancer	0.000294	0.147	CrCbGaD
Caffeine—ADORA1—lung—hematologic cancer	0.000281	0.00867	CbGeAlD
Caffeine—PDE4B—gonad—hematologic cancer	0.000272	0.00839	CbGeAlD
Caffeine—Pentoxifylline—PDE4B—hematologic cancer	0.000266	0.133	CrCbGaD
Caffeine—ADORA1—testis—hematologic cancer	0.000265	0.00818	CbGeAlD
Caffeine—Oxtriphylline—PDE4B—hematologic cancer	0.000254	0.127	CrCbGaD
Caffeine—PDE4B—blood—hematologic cancer	0.000237	0.00731	CbGeAlD
Caffeine—CYP2C8—hematopoietic system—hematologic cancer	0.000235	0.00724	CbGeAlD
Caffeine—CYP1B1—gonad—hematologic cancer	0.000234	0.00719	CbGeAlD
Caffeine—PDE4B—bone marrow—hematologic cancer	0.00023	0.00708	CbGeAlD
Caffeine—CYP1A2—hematopoietic system—hematologic cancer	0.00022	0.00678	CbGeAlD
Caffeine—CYP1A1—hematopoietic system—hematologic cancer	0.000217	0.00669	CbGeAlD
Caffeine—Dyphylline—PDE4B—hematologic cancer	0.000216	0.108	CrCbGaD
Caffeine—CYP3A5—hematopoietic system—hematologic cancer	0.000212	0.00654	CbGeAlD
Caffeine—CYP2C9—hematopoietic system—hematologic cancer	0.000209	0.00643	CbGeAlD
Caffeine—PDE4B—lung—hematologic cancer	0.000208	0.00641	CbGeAlD
Caffeine—CYP1B1—blood—hematologic cancer	0.000203	0.00627	CbGeAlD
Caffeine—CYP2E1—hematopoietic system—hematologic cancer	0.000198	0.0061	CbGeAlD
Caffeine—PDE4B—testis—hematologic cancer	0.000196	0.00605	CbGeAlD
Caffeine—ADORA1—lymph node—hematologic cancer	0.000192	0.00593	CbGeAlD
Caffeine—CYP1B1—lung—hematologic cancer	0.000178	0.00549	CbGeAlD
Caffeine—CYP1B1—testis—hematologic cancer	0.000168	0.00518	CbGeAlD
Caffeine—CYP3A4—hematopoietic system—hematologic cancer	0.000159	0.00491	CbGeAlD
Caffeine—CYP2D6—hematopoietic system—hematologic cancer	0.000157	0.00483	CbGeAlD
Caffeine—CYP2C8—blood—hematologic cancer	0.000156	0.0048	CbGeAlD
Caffeine—Theophylline—PDE4B—hematologic cancer	0.000154	0.0769	CrCbGaD
Caffeine—CYP1A2—blood—hematologic cancer	0.000146	0.00449	CbGeAlD
Caffeine—CYP1A1—blood—hematologic cancer	0.000144	0.00443	CbGeAlD
Caffeine—PDE4B—lymph node—hematologic cancer	0.000142	0.00438	CbGeAlD
Caffeine—CYP3A5—blood—hematologic cancer	0.000141	0.00433	CbGeAlD
Caffeine—CYP2C9—blood—hematologic cancer	0.000138	0.00426	CbGeAlD
Caffeine—CYP2E1—blood—hematologic cancer	0.000131	0.00404	CbGeAlD
Caffeine—CYP2C8—testis—hematologic cancer	0.000129	0.00397	CbGeAlD
Caffeine—CYP1A2—lung—hematologic cancer	0.000128	0.00394	CbGeAlD
Caffeine—CYP1A1—lung—hematologic cancer	0.000126	0.00388	CbGeAlD
Caffeine—CYP3A5—lung—hematologic cancer	0.000123	0.0038	CbGeAlD
Caffeine—CYP1B1—lymph node—hematologic cancer	0.000122	0.00376	CbGeAlD
Caffeine—PRKDC—Testosterone—Prednisolone—hematologic cancer	0.000121	0.108	CbGdCrCtD
Caffeine—CYP2E1—lung—hematologic cancer	0.000115	0.00354	CbGeAlD
Caffeine—ABCB1—hematopoietic system—hematologic cancer	0.000113	0.00347	CbGeAlD
Caffeine—CYP2E1—testis—hematologic cancer	0.000109	0.00334	CbGeAlD
Caffeine—CYP3A4—blood—hematologic cancer	0.000106	0.00325	CbGeAlD
Caffeine—CYP2D6—blood—hematologic cancer	0.000104	0.0032	CbGeAlD
Caffeine—PRKDC—Danazol—Prednisone—hematologic cancer	0.0001	0.0901	CbGdCrCtD
Caffeine—CYP1A1—lymph node—hematologic cancer	8.62e-05	0.00266	CbGeAlD
Caffeine—CYP2D6—testis—hematologic cancer	8.59e-05	0.00265	CbGeAlD
Caffeine—ABCB1—gonad—hematologic cancer	8.57e-05	0.00264	CbGeAlD
Caffeine—ABCB1—blood—hematologic cancer	7.47e-05	0.0023	CbGeAlD
Caffeine—ABCB1—bone marrow—hematologic cancer	7.23e-05	0.00223	CbGeAlD
Caffeine—ABCB1—lung—hematologic cancer	6.55e-05	0.00202	CbGeAlD
Caffeine—ABCB1—testis—hematologic cancer	6.18e-05	0.0019	CbGeAlD
Caffeine—ABCB1—lymph node—hematologic cancer	4.48e-05	0.00138	CbGeAlD
Caffeine—Cardiac disorder—Etoposide—hematologic cancer	4.01e-05	0.000558	CcSEcCtD
Caffeine—Hypertension—Vincristine—hematologic cancer	4.01e-05	0.000558	CcSEcCtD
Caffeine—Hyperglycaemia—Betamethasone—hematologic cancer	4.01e-05	0.000557	CcSEcCtD
Caffeine—Hyperglycaemia—Dexamethasone—hematologic cancer	4.01e-05	0.000557	CcSEcCtD
Caffeine—Rash—Procarbazine—hematologic cancer	4e-05	0.000556	CcSEcCtD
Caffeine—Dermatitis—Procarbazine—hematologic cancer	4e-05	0.000556	CcSEcCtD
Caffeine—Dyspnoea—Vinorelbine—hematologic cancer	3.99e-05	0.000555	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—hematologic cancer	3.97e-05	0.000553	CcSEcCtD
Caffeine—Hypersensitivity—Vinblastine—hematologic cancer	3.97e-05	0.000552	CcSEcCtD
Caffeine—Gastrointestinal disorder—Bortezomib—hematologic cancer	3.96e-05	0.00055	CcSEcCtD
Caffeine—Infection—Carmustine—hematologic cancer	3.95e-05	0.000549	CcSEcCtD
Caffeine—Haemoglobin—Triamcinolone—hematologic cancer	3.94e-05	0.000548	CcSEcCtD
Caffeine—Rash—Bexarotene—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Rash—Dasatinib—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Haemorrhage—Triamcinolone—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Dermatitis—Bexarotene—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Dermatitis—Dasatinib—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Convulsion—Mitoxantrone—hematologic cancer	3.92e-05	0.000545	CcSEcCtD
Caffeine—Rash—Fludarabine—hematologic cancer	3.91e-05	0.000544	CcSEcCtD
Caffeine—Dermatitis—Fludarabine—hematologic cancer	3.91e-05	0.000543	CcSEcCtD
Caffeine—Infection—Alitretinoin—hematologic cancer	3.91e-05	0.000543	CcSEcCtD
Caffeine—Hypertension—Mitoxantrone—hematologic cancer	3.91e-05	0.000543	CcSEcCtD
Caffeine—Hypertension—Irinotecan—hematologic cancer	3.91e-05	0.000543	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—hematologic cancer	3.91e-05	0.000543	CcSEcCtD
Caffeine—Tachycardia—Carmustine—hematologic cancer	3.88e-05	0.000539	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—hematologic cancer	3.88e-05	0.000539	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vinorelbine—hematologic cancer	3.87e-05	0.000537	CcSEcCtD
Caffeine—Infection—Ifosfamide—hematologic cancer	3.86e-05	0.000537	CcSEcCtD
Caffeine—Nervous system disorder—Alitretinoin—hematologic cancer	3.86e-05	0.000536	CcSEcCtD
Caffeine—Tachycardia—Alitretinoin—hematologic cancer	3.84e-05	0.000534	CcSEcCtD
Caffeine—Skin disorder—Alitretinoin—hematologic cancer	3.82e-05	0.000531	CcSEcCtD
Caffeine—Nervous system disorder—Ifosfamide—hematologic cancer	3.81e-05	0.00053	CcSEcCtD
Caffeine—Hypertension—Gemcitabine—hematologic cancer	3.81e-05	0.000529	CcSEcCtD
Caffeine—Skin disorder—Ifosfamide—hematologic cancer	3.78e-05	0.000525	CcSEcCtD
Caffeine—Hypersensitivity—Melphalan—hematologic cancer	3.78e-05	0.000525	CcSEcCtD
Caffeine—Infection—Vincristine—hematologic cancer	3.77e-05	0.000524	CcSEcCtD
Caffeine—Nervous system disorder—Vincristine—hematologic cancer	3.72e-05	0.000517	CcSEcCtD
Caffeine—Gastrointestinal disorder—Thiotepa—hematologic cancer	3.69e-05	0.000513	CcSEcCtD
Caffeine—Dyspnoea—Thalidomide—hematologic cancer	3.69e-05	0.000513	CcSEcCtD
Caffeine—Hypersensitivity—Lenalidomide—hematologic cancer	3.67e-05	0.00051	CcSEcCtD
Caffeine—Infection—Irinotecan—hematologic cancer	3.67e-05	0.00051	CcSEcCtD
Caffeine—Infection—Mitoxantrone—hematologic cancer	3.67e-05	0.00051	CcSEcCtD
Caffeine—Rash—Nilotinib—hematologic cancer	3.63e-05	0.000504	CcSEcCtD
Caffeine—Dermatitis—Nilotinib—hematologic cancer	3.62e-05	0.000504	CcSEcCtD
Caffeine—Nervous system disorder—Irinotecan—hematologic cancer	3.62e-05	0.000503	CcSEcCtD
Caffeine—Hypersensitivity—Hydroxyurea—hematologic cancer	3.62e-05	0.000503	CcSEcCtD
Caffeine—Rash—Imatinib—hematologic cancer	3.61e-05	0.000501	CcSEcCtD
Caffeine—Tachycardia—Mitoxantrone—hematologic cancer	3.6e-05	0.000501	CcSEcCtD
Caffeine—Dermatitis—Imatinib—hematologic cancer	3.6e-05	0.000501	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—hematologic cancer	3.59e-05	0.000499	CcSEcCtD
Caffeine—Skin disorder—Mitoxantrone—hematologic cancer	3.59e-05	0.000499	CcSEcCtD
Caffeine—Haemoglobin—Betamethasone—hematologic cancer	3.58e-05	0.000497	CcSEcCtD
Caffeine—Haemoglobin—Dexamethasone—hematologic cancer	3.58e-05	0.000497	CcSEcCtD
Caffeine—Infection—Gemcitabine—hematologic cancer	3.57e-05	0.000497	CcSEcCtD
Caffeine—Irritability—Methotrexate—hematologic cancer	3.57e-05	0.000497	CcSEcCtD
Caffeine—Gastrointestinal disorder—Thalidomide—hematologic cancer	3.57e-05	0.000496	CcSEcCtD
Caffeine—Convulsion—Cisplatin—hematologic cancer	3.56e-05	0.000495	CcSEcCtD
Caffeine—Haemorrhage—Dexamethasone—hematologic cancer	3.56e-05	0.000495	CcSEcCtD
Caffeine—Haemorrhage—Betamethasone—hematologic cancer	3.56e-05	0.000495	CcSEcCtD
Caffeine—Rash—Cladribine—hematologic cancer	3.54e-05	0.000492	CcSEcCtD
Caffeine—Dyspnoea—Carmustine—hematologic cancer	3.54e-05	0.000492	CcSEcCtD
Caffeine—Dermatitis—Cladribine—hematologic cancer	3.54e-05	0.000492	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—hematologic cancer	3.53e-05	0.00049	CcSEcCtD
Caffeine—Dyspnoea—Alitretinoin—hematologic cancer	3.51e-05	0.000488	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—hematologic cancer	3.5e-05	0.000487	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—hematologic cancer	3.49e-05	0.000486	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—hematologic cancer	3.49e-05	0.000485	CcSEcCtD
Caffeine—Dyspnoea—Ifosfamide—hematologic cancer	3.47e-05	0.000482	CcSEcCtD
Caffeine—Gastrointestinal disorder—Carmustine—hematologic cancer	3.43e-05	0.000477	CcSEcCtD
Caffeine—Gastrointestinal disorder—Alitretinoin—hematologic cancer	3.4e-05	0.000472	CcSEcCtD
Caffeine—Hypersensitivity—Bortezomib—hematologic cancer	3.38e-05	0.00047	CcSEcCtD
Caffeine—Gastrointestinal disorder—Ifosfamide—hematologic cancer	3.36e-05	0.000467	CcSEcCtD
Caffeine—Hypersensitivity—Bleomycin—hematologic cancer	3.35e-05	0.000466	CcSEcCtD
Caffeine—Infection—Cisplatin—hematologic cancer	3.33e-05	0.000463	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—hematologic cancer	3.32e-05	0.000462	CcSEcCtD
Caffeine—Hypersensitivity—Vinorelbine—hematologic cancer	3.3e-05	0.000459	CcSEcCtD
Caffeine—Dyspnoea—Mitoxantrone—hematologic cancer	3.29e-05	0.000458	CcSEcCtD
Caffeine—Dyspnoea—Irinotecan—hematologic cancer	3.29e-05	0.000458	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—hematologic cancer	3.29e-05	0.000457	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—hematologic cancer	3.28e-05	0.000456	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—hematologic cancer	3.27e-05	0.000455	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—hematologic cancer	3.27e-05	0.000455	CcSEcCtD
Caffeine—Convulsion—Etoposide—hematologic cancer	3.26e-05	0.000453	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—hematologic cancer	3.26e-05	0.000453	CcSEcCtD
Caffeine—Hypertension—Etoposide—hematologic cancer	3.25e-05	0.000452	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—hematologic cancer	3.24e-05	0.000451	CcSEcCtD
Caffeine—Rash—Melphalan—hematologic cancer	3.23e-05	0.000449	CcSEcCtD
Caffeine—Dermatitis—Melphalan—hematologic cancer	3.23e-05	0.000449	CcSEcCtD
Caffeine—Convulsion—Prednisolone—hematologic cancer	3.22e-05	0.000447	CcSEcCtD
Caffeine—Dry skin—Epirubicin—hematologic cancer	3.21e-05	0.000446	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—hematologic cancer	3.21e-05	0.000446	CcSEcCtD
Caffeine—Hypertension—Prednisolone—hematologic cancer	3.21e-05	0.000446	CcSEcCtD
Caffeine—Gastrointestinal disorder—Irinotecan—hematologic cancer	3.19e-05	0.000443	CcSEcCtD
Caffeine—Hypersensitivity—Thiotepa—hematologic cancer	3.15e-05	0.000438	CcSEcCtD
Caffeine—Rash—Lenalidomide—hematologic cancer	3.14e-05	0.000437	CcSEcCtD
Caffeine—Dermatitis—Lenalidomide—hematologic cancer	3.14e-05	0.000436	CcSEcCtD
Caffeine—Haemoglobin—Prednisone—hematologic cancer	3.11e-05	0.000433	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gemcitabine—hematologic cancer	3.11e-05	0.000432	CcSEcCtD
Caffeine—Gastritis—Epirubicin—hematologic cancer	3.1e-05	0.000431	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—hematologic cancer	3.1e-05	0.000431	CcSEcCtD
Caffeine—Rash—Hydroxyurea—hematologic cancer	3.1e-05	0.000431	CcSEcCtD
Caffeine—Dermatitis—Hydroxyurea—hematologic cancer	3.1e-05	0.00043	CcSEcCtD
Caffeine—Infection—Etoposide—hematologic cancer	3.05e-05	0.000424	CcSEcCtD
Caffeine—Hypersensitivity—Thalidomide—hematologic cancer	3.05e-05	0.000424	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—hematologic cancer	3.04e-05	0.000422	CcSEcCtD
Caffeine—Tachycardia—Etoposide—hematologic cancer	3e-05	0.000417	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—hematologic cancer	2.99e-05	0.000416	CcSEcCtD
Caffeine—Skin disorder—Etoposide—hematologic cancer	2.98e-05	0.000415	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—hematologic cancer	2.97e-05	0.000413	CcSEcCtD
Caffeine—Convulsion—Triamcinolone—hematologic cancer	2.96e-05	0.000411	CcSEcCtD
Caffeine—Tachycardia—Prednisolone—hematologic cancer	2.96e-05	0.000411	CcSEcCtD
Caffeine—Hypertension—Triamcinolone—hematologic cancer	2.95e-05	0.00041	CcSEcCtD
Caffeine—Hypersensitivity—Carmustine—hematologic cancer	2.93e-05	0.000407	CcSEcCtD
Caffeine—Hypersensitivity—Alitretinoin—hematologic cancer	2.9e-05	0.000403	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cisplatin—hematologic cancer	2.89e-05	0.000402	CcSEcCtD
Caffeine—Rash—Bortezomib—hematologic cancer	2.89e-05	0.000402	CcSEcCtD
Caffeine—Dermatitis—Bortezomib—hematologic cancer	2.89e-05	0.000402	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—hematologic cancer	2.89e-05	0.000401	CcSEcCtD
Caffeine—Infestation—Methotrexate—hematologic cancer	2.89e-05	0.000401	CcSEcCtD
Caffeine—Rash—Bleomycin—hematologic cancer	2.87e-05	0.000399	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—hematologic cancer	2.87e-05	0.000399	CcSEcCtD
Caffeine—Dermatitis—Bleomycin—hematologic cancer	2.87e-05	0.000398	CcSEcCtD
Caffeine—Hypersensitivity—Ifosfamide—hematologic cancer	2.87e-05	0.000398	CcSEcCtD
Caffeine—Renal failure—Methotrexate—hematologic cancer	2.84e-05	0.000394	CcSEcCtD
Caffeine—Rash—Vinorelbine—hematologic cancer	2.82e-05	0.000392	CcSEcCtD
Caffeine—Dermatitis—Vinorelbine—hematologic cancer	2.82e-05	0.000392	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—hematologic cancer	2.8e-05	0.000389	CcSEcCtD
Caffeine—Hypersensitivity—Vincristine—hematologic cancer	2.79e-05	0.000388	CcSEcCtD
Caffeine—Infection—Triamcinolone—hematologic cancer	2.77e-05	0.000385	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—hematologic cancer	2.74e-05	0.000381	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—hematologic cancer	2.73e-05	0.00038	CcSEcCtD
Caffeine—Hypersensitivity—Mitoxantrone—hematologic cancer	2.72e-05	0.000378	CcSEcCtD
Caffeine—Hypersensitivity—Irinotecan—hematologic cancer	2.72e-05	0.000378	CcSEcCtD
Caffeine—Tachycardia—Triamcinolone—hematologic cancer	2.72e-05	0.000378	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—hematologic cancer	2.7e-05	0.000375	CcSEcCtD
Caffeine—Infestation—Epirubicin—hematologic cancer	2.7e-05	0.000375	CcSEcCtD
Caffeine—Malnutrition—Prednisone—hematologic cancer	2.7e-05	0.000375	CcSEcCtD
Caffeine—Rash—Thiotepa—hematologic cancer	2.7e-05	0.000375	CcSEcCtD
Caffeine—Dermatitis—Thiotepa—hematologic cancer	2.69e-05	0.000374	CcSEcCtD
Caffeine—Convulsion—Dexamethasone—hematologic cancer	2.68e-05	0.000373	CcSEcCtD
Caffeine—Convulsion—Betamethasone—hematologic cancer	2.68e-05	0.000373	CcSEcCtD
Caffeine—Hypertension—Dexamethasone—hematologic cancer	2.67e-05	0.000372	CcSEcCtD
Caffeine—Hypertension—Betamethasone—hematologic cancer	2.67e-05	0.000372	CcSEcCtD
Caffeine—Renal failure—Epirubicin—hematologic cancer	2.65e-05	0.000369	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—hematologic cancer	2.65e-05	0.000369	CcSEcCtD
Caffeine—Rash—Thalidomide—hematologic cancer	2.61e-05	0.000362	CcSEcCtD
Caffeine—Dermatitis—Thalidomide—hematologic cancer	2.61e-05	0.000362	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—hematologic cancer	2.6e-05	0.000362	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—hematologic cancer	2.59e-05	0.00036	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—hematologic cancer	2.53e-05	0.000351	CcSEcCtD
Caffeine—Infection—Betamethasone—hematologic cancer	2.51e-05	0.000349	CcSEcCtD
Caffeine—Infection—Dexamethasone—hematologic cancer	2.51e-05	0.000349	CcSEcCtD
Caffeine—Rash—Carmustine—hematologic cancer	2.5e-05	0.000348	CcSEcCtD
Caffeine—Dermatitis—Carmustine—hematologic cancer	2.5e-05	0.000348	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—hematologic cancer	2.5e-05	0.000347	CcSEcCtD
Caffeine—Infestation—Doxorubicin—hematologic cancer	2.5e-05	0.000347	CcSEcCtD
Caffeine—Dyspnoea—Triamcinolone—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Rash—Alitretinoin—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Nervous system disorder—Dexamethasone—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Nervous system disorder—Betamethasone—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Agitation—Prednisone—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Dermatitis—Alitretinoin—hematologic cancer	2.48e-05	0.000345	CcSEcCtD
Caffeine—Hypersensitivity—Cisplatin—hematologic cancer	2.47e-05	0.000343	CcSEcCtD
Caffeine—Tachycardia—Dexamethasone—hematologic cancer	2.47e-05	0.000343	CcSEcCtD
Caffeine—Tachycardia—Betamethasone—hematologic cancer	2.47e-05	0.000343	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—hematologic cancer	2.46e-05	0.000341	CcSEcCtD
Caffeine—Rash—Ifosfamide—hematologic cancer	2.45e-05	0.000341	CcSEcCtD
Caffeine—Dermatitis—Ifosfamide—hematologic cancer	2.45e-05	0.000341	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—hematologic cancer	2.44e-05	0.000339	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—hematologic cancer	2.42e-05	0.000337	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—hematologic cancer	2.4e-05	0.000334	CcSEcCtD
Caffeine—Rash—Vincristine—hematologic cancer	2.39e-05	0.000332	CcSEcCtD
Caffeine—Dermatitis—Vincristine—hematologic cancer	2.39e-05	0.000332	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—hematologic cancer	2.34e-05	0.000325	CcSEcCtD
Caffeine—Convulsion—Prednisone—hematologic cancer	2.34e-05	0.000325	CcSEcCtD
Caffeine—Hypertension—Prednisone—hematologic cancer	2.33e-05	0.000324	CcSEcCtD
Caffeine—Rash—Mitoxantrone—hematologic cancer	2.33e-05	0.000324	CcSEcCtD
Caffeine—Rash—Irinotecan—hematologic cancer	2.33e-05	0.000324	CcSEcCtD
Caffeine—Dermatitis—Mitoxantrone—hematologic cancer	2.33e-05	0.000323	CcSEcCtD
Caffeine—Dermatitis—Irinotecan—hematologic cancer	2.33e-05	0.000323	CcSEcCtD
Caffeine—Rash—Gemcitabine—hematologic cancer	2.27e-05	0.000315	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—hematologic cancer	2.27e-05	0.000315	CcSEcCtD
Caffeine—Hypersensitivity—Etoposide—hematologic cancer	2.26e-05	0.000315	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—hematologic cancer	2.25e-05	0.000313	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—hematologic cancer	2.25e-05	0.000313	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—hematologic cancer	2.25e-05	0.000313	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—hematologic cancer	2.24e-05	0.000312	CcSEcCtD
Caffeine—Hypersensitivity—Prednisolone—hematologic cancer	2.23e-05	0.00031	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—hematologic cancer	2.19e-05	0.000304	CcSEcCtD
Caffeine—Infection—Prednisone—hematologic cancer	2.19e-05	0.000304	CcSEcCtD
Caffeine—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.18e-05	0.000303	CcSEcCtD
Caffeine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.18e-05	0.000303	CcSEcCtD
Caffeine—Nervous system disorder—Prednisone—hematologic cancer	2.16e-05	0.0003	CcSEcCtD
Caffeine—Tachycardia—Prednisone—hematologic cancer	2.15e-05	0.000299	CcSEcCtD
Caffeine—Skin disorder—Prednisone—hematologic cancer	2.14e-05	0.000297	CcSEcCtD
Caffeine—Rash—Cisplatin—hematologic cancer	2.11e-05	0.000294	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—hematologic cancer	2.11e-05	0.000294	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—hematologic cancer	2.11e-05	0.000293	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—hematologic cancer	2.08e-05	0.000289	CcSEcCtD
Caffeine—Hypersensitivity—Triamcinolone—hematologic cancer	2.05e-05	0.000285	CcSEcCtD
Caffeine—Nervousness—Epirubicin—hematologic cancer	2.05e-05	0.000285	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—hematologic cancer	2.03e-05	0.000282	CcSEcCtD
Caffeine—Convulsion—Methotrexate—hematologic cancer	1.95e-05	0.000272	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—hematologic cancer	1.95e-05	0.000271	CcSEcCtD
Caffeine—Agitation—Epirubicin—hematologic cancer	1.94e-05	0.000269	CcSEcCtD
Caffeine—Rash—Etoposide—hematologic cancer	1.94e-05	0.000269	CcSEcCtD
Caffeine—Dermatitis—Etoposide—hematologic cancer	1.94e-05	0.000269	CcSEcCtD
Caffeine—Rash—Prednisolone—hematologic cancer	1.91e-05	0.000266	CcSEcCtD
Caffeine—Dermatitis—Prednisolone—hematologic cancer	1.91e-05	0.000265	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—hematologic cancer	1.9e-05	0.000264	CcSEcCtD
Caffeine—Convulsion—Epirubicin—hematologic cancer	1.83e-05	0.000254	CcSEcCtD
Caffeine—Infection—Methotrexate—hematologic cancer	1.83e-05	0.000254	CcSEcCtD
Caffeine—Hypertension—Epirubicin—hematologic cancer	1.82e-05	0.000253	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—hematologic cancer	1.8e-05	0.000251	CcSEcCtD
Caffeine—Agitation—Doxorubicin—hematologic cancer	1.79e-05	0.000249	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—hematologic cancer	1.79e-05	0.000248	CcSEcCtD
Caffeine—Rash—Triamcinolone—hematologic cancer	1.76e-05	0.000244	CcSEcCtD
Caffeine—Dermatitis—Triamcinolone—hematologic cancer	1.76e-05	0.000244	CcSEcCtD
Caffeine—Infection—Epirubicin—hematologic cancer	1.71e-05	0.000238	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—hematologic cancer	1.69e-05	0.000235	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—hematologic cancer	1.69e-05	0.000235	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—hematologic cancer	1.69e-05	0.000234	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—hematologic cancer	1.68e-05	0.000234	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—hematologic cancer	1.67e-05	0.000232	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—hematologic cancer	1.64e-05	0.000228	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—hematologic cancer	1.62e-05	0.000225	CcSEcCtD
Caffeine—Rash—Dexamethasone—hematologic cancer	1.59e-05	0.000222	CcSEcCtD
Caffeine—Rash—Betamethasone—hematologic cancer	1.59e-05	0.000222	CcSEcCtD
Caffeine—Dermatitis—Dexamethasone—hematologic cancer	1.59e-05	0.000221	CcSEcCtD
Caffeine—Dermatitis—Betamethasone—hematologic cancer	1.59e-05	0.000221	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.59e-05	0.000221	CcSEcCtD
Caffeine—Infection—Doxorubicin—hematologic cancer	1.58e-05	0.00022	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—hematologic cancer	1.56e-05	0.000217	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—hematologic cancer	1.56e-05	0.000216	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—hematologic cancer	1.55e-05	0.000215	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—hematologic cancer	1.54e-05	0.000213	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.49e-05	0.000207	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—hematologic cancer	1.42e-05	0.000197	CcSEcCtD
Caffeine—Rash—Prednisone—hematologic cancer	1.39e-05	0.000193	CcSEcCtD
Caffeine—Dermatitis—Prednisone—hematologic cancer	1.39e-05	0.000193	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.38e-05	0.000191	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—hematologic cancer	1.36e-05	0.000188	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—hematologic cancer	1.27e-05	0.000176	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—hematologic cancer	1.17e-05	0.000163	CcSEcCtD
Caffeine—Rash—Methotrexate—hematologic cancer	1.16e-05	0.000161	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—hematologic cancer	1.16e-05	0.000161	CcSEcCtD
Caffeine—Rash—Epirubicin—hematologic cancer	1.09e-05	0.000151	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—hematologic cancer	1.08e-05	0.000151	CcSEcCtD
Caffeine—Rash—Doxorubicin—hematologic cancer	1e-05	0.00014	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—hematologic cancer	1e-05	0.00014	CcSEcCtD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.65e-07	3.61e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.63e-07	3.59e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.63e-07	3.59e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—hematologic cancer	3.62e-07	3.58e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—hematologic cancer	3.62e-07	3.58e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—hematologic cancer	3.62e-07	3.58e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	3.61e-07	3.57e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.61e-07	3.57e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3R1—hematologic cancer	3.61e-07	3.57e-06	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—hematologic cancer	3.61e-07	3.57e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NCOR1—hematologic cancer	3.6e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTM1—hematologic cancer	3.6e-07	3.56e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—hematologic cancer	3.6e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.59e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.59e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.59e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TXN—hematologic cancer	3.59e-07	3.55e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—hematologic cancer	3.57e-07	3.53e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYCS—hematologic cancer	3.55e-07	3.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.55e-07	3.51e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.54e-07	3.5e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CD44—hematologic cancer	3.54e-07	3.5e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—hematologic cancer	3.54e-07	3.5e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.53e-07	3.49e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—hematologic cancer	3.53e-07	3.49e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.53e-07	3.49e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK3—hematologic cancer	3.52e-07	3.48e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—hematologic cancer	3.52e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.51e-07	3.47e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.51e-07	3.47e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CD44—hematologic cancer	3.51e-07	3.47e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.48e-07	3.44e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—hematologic cancer	3.46e-07	3.42e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.44e-07	3.41e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.43e-07	3.4e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—hematologic cancer	3.43e-07	3.39e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFB1—hematologic cancer	3.42e-07	3.38e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—hematologic cancer	3.41e-07	3.38e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—hematologic cancer	3.41e-07	3.37e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—hematologic cancer	3.4e-07	3.36e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.4e-07	3.36e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—hematologic cancer	3.4e-07	3.36e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—hematologic cancer	3.39e-07	3.35e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—hematologic cancer	3.38e-07	3.35e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—hematologic cancer	3.38e-07	3.35e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.38e-07	3.34e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.38e-07	3.34e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.37e-07	3.33e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.37e-07	3.33e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.35e-07	3.31e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—hematologic cancer	3.34e-07	3.31e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK8—hematologic cancer	3.33e-07	3.29e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CB—hematologic cancer	3.33e-07	3.29e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.33e-07	3.29e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.32e-07	3.29e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—hematologic cancer	3.32e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.32e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.3e-07	3.27e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.3e-07	3.27e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.3e-07	3.26e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.28e-07	3.25e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.28e-07	3.25e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—hematologic cancer	3.27e-07	3.23e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.25e-07	3.22e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EP300—hematologic cancer	3.25e-07	3.21e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—hematologic cancer	3.24e-07	3.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.2e-07	3.16e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTHFR—hematologic cancer	3.18e-07	3.15e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.18e-07	3.14e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—hematologic cancer	3.17e-07	3.13e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—hematologic cancer	3.16e-07	3.12e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—hematologic cancer	3.13e-07	3.1e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	3.11e-07	3.07e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.1e-07	3.06e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—hematologic cancer	3.07e-07	3.04e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	3.07e-07	3.04e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—hematologic cancer	3.04e-07	3.01e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—hematologic cancer	3.04e-07	3e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—hematologic cancer	3.02e-07	2.98e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.01e-07	2.97e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.01e-07	2.97e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—hematologic cancer	3.01e-07	2.97e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3e-07	2.97e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NQO1—hematologic cancer	3e-07	2.96e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CD44—hematologic cancer	3e-07	2.96e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—hematologic cancer	2.99e-07	2.95e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.99e-07	2.95e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—hematologic cancer	2.97e-07	2.94e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.97e-07	2.93e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.95e-07	2.92e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.94e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTR—hematologic cancer	2.93e-07	2.89e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.93e-07	2.89e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.93e-07	2.89e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.92e-07	2.89e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—hematologic cancer	2.91e-07	2.88e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.88e-07	2.85e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.88e-07	2.85e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—hematologic cancer	2.88e-07	2.84e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—hematologic cancer	2.88e-07	2.84e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.87e-07	2.84e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—hematologic cancer	2.84e-07	2.81e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—hematologic cancer	2.84e-07	2.81e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.84e-07	2.81e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.84e-07	2.8e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.83e-07	2.8e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.83e-07	2.8e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—hematologic cancer	2.83e-07	2.8e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—hematologic cancer	2.82e-07	2.79e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.82e-07	2.79e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—hematologic cancer	2.81e-07	2.78e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.81e-07	2.77e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.79e-07	2.76e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.78e-07	2.75e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.77e-07	2.74e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—hematologic cancer	2.75e-07	2.72e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—hematologic cancer	2.74e-07	2.71e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—hematologic cancer	2.72e-07	2.69e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.72e-07	2.69e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.71e-07	2.68e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.71e-07	2.68e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—hematologic cancer	2.69e-07	2.66e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.69e-07	2.66e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.69e-07	2.66e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.68e-07	2.65e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.63e-07	2.6e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.63e-07	2.6e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—hematologic cancer	2.61e-07	2.58e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—hematologic cancer	2.59e-07	2.56e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—hematologic cancer	2.58e-07	2.55e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.57e-07	2.54e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.54e-07	2.51e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—hematologic cancer	2.54e-07	2.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.54e-07	2.51e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—hematologic cancer	2.51e-07	2.48e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.5e-07	2.47e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.49e-07	2.47e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.49e-07	2.46e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.48e-07	2.45e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—hematologic cancer	2.47e-07	2.45e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—hematologic cancer	2.46e-07	2.44e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—hematologic cancer	2.46e-07	2.43e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.45e-07	2.43e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.42e-07	2.39e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—hematologic cancer	2.4e-07	2.37e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.4e-07	2.37e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.38e-07	2.35e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—hematologic cancer	2.38e-07	2.35e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.37e-07	2.34e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.36e-07	2.33e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.35e-07	2.33e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.35e-07	2.32e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—hematologic cancer	2.32e-07	2.3e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—hematologic cancer	2.32e-07	2.3e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.31e-07	2.29e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CD44—hematologic cancer	2.31e-07	2.29e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.3e-07	2.27e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.3e-07	2.27e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.27e-07	2.25e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—hematologic cancer	2.22e-07	2.2e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.22e-07	2.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.19e-07	2.16e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.18e-07	2.15e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.17e-07	2.15e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.17e-07	2.15e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.16e-07	2.13e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.14e-07	2.11e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—hematologic cancer	2.13e-07	2.1e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—hematologic cancer	2.13e-07	2.1e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.09e-07	2.07e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.05e-07	2.03e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.04e-07	2.01e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.03e-07	2.01e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—hematologic cancer	2.03e-07	2.01e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.01e-07	1.99e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2e-07	1.97e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.98e-07	1.96e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—hematologic cancer	1.96e-07	1.94e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.93e-07	1.91e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.88e-07	1.86e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.88e-07	1.86e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.88e-07	1.86e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.88e-07	1.85e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.87e-07	1.85e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—hematologic cancer	1.85e-07	1.83e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.85e-07	1.83e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.83e-07	1.81e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.83e-07	1.81e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—hematologic cancer	1.79e-07	1.77e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.79e-07	1.77e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—hematologic cancer	1.79e-07	1.77e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.77e-07	1.75e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.77e-07	1.75e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.77e-07	1.75e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—hematologic cancer	1.77e-07	1.75e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.77e-07	1.75e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.76e-07	1.74e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—hematologic cancer	1.75e-07	1.73e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—hematologic cancer	1.73e-07	1.71e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.71e-07	1.69e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—hematologic cancer	1.69e-07	1.67e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.67e-07	1.65e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—hematologic cancer	1.66e-07	1.64e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.66e-07	1.64e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.64e-07	1.62e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.62e-07	1.61e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.58e-07	1.56e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.57e-07	1.55e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—hematologic cancer	1.55e-07	1.53e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.54e-07	1.53e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.53e-07	1.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.5e-07	1.48e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—hematologic cancer	1.49e-07	1.48e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—hematologic cancer	1.48e-07	1.46e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.42e-07	1.4e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—hematologic cancer	1.41e-07	1.4e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—hematologic cancer	1.35e-07	1.33e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.33e-07	1.32e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.33e-07	1.31e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.32e-07	1.31e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.32e-07	1.31e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.32e-07	1.3e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.31e-07	1.29e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—hematologic cancer	1.27e-07	1.26e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—hematologic cancer	1.26e-07	1.25e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.25e-07	1.24e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.22e-07	1.21e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.16e-07	1.14e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.15e-07	1.13e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—hematologic cancer	1.14e-07	1.13e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.13e-07	1.12e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.09e-07	1.08e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.08e-07	1.07e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.08e-07	1.07e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—hematologic cancer	1.08e-07	1.07e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—hematologic cancer	1.02e-07	1.01e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.01e-07	9.98e-07	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.98e-08	9.87e-07	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.41e-08	9.3e-07	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—hematologic cancer	9.36e-08	9.25e-07	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.33e-08	9.22e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.72e-08	8.62e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—hematologic cancer	8.31e-08	8.22e-07	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—hematologic cancer	8.15e-08	8.06e-07	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.97e-08	7.88e-07	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.68e-08	7.6e-07	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.62e-08	7.53e-07	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.51e-08	6.44e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.15e-08	6.08e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.02e-08	4.97e-07	CbGpPWpGaD
